AOD-9604 + CJC-1295 + Ipamorelin: The Three-Peptide Fat-Loss Blend
Also known as: AOD-9604 + CJC-1295 + Ipamorelin · AOD blend · Fat-loss peptide blend
A three-peptide blend marketed for fat loss. The CJC-1295 and ipamorelin half follows the established GHRH-plus-GHRP logic. AOD-9604 is the part that needs a straight answer: it is a fragment of human growth hormone developed specifically as an anti-obesity drug, and in its own phase-2b clinical trial it did not produce significantly greater weight loss than placebo. It was subsequently repositioned away from obesity. Adding a compound that failed its primary endpoint to a blend does not make the blend better at that endpoint. Educational only, not medical advice.
What AOD-9604 is and what happened to it
AOD-9604 is a short fragment of the C-terminal end of human growth hormone — the region associated with GH's fat-metabolising effects — engineered with the intention of separating that action from GH's effects on growth and blood sugar. On paper it is an elegant idea: the fat-loss part of GH without the rest.
It was developed as an obesity drug and taken into human trials. In phase 2b it did not achieve significantly greater weight loss than placebo, and development for obesity did not continue on that path. That is not an ambiguous or contested result; it is the reason the compound is not an approved weight-loss drug today.
It has since been explored for other purposes, including cartilage and joint applications, which is a different question with its own thin evidence base. What it does not have is a demonstrated fat-loss effect in humans.
What the blend is actually doing
Strip out AOD-9604 and what remains is a standard CJC-1295 plus ipamorelin blend, with the mechanistic support and the evidence limits described on that page. Any GH-mediated effect this product has is coming from that pairing.
The three-peptide format is also the least controllable. A fixed ratio of three compounds means the dose of each is locked to the others, and blends of three are more variable between sellers than two-component ones. The number of compounds in the vial is not a measure of how well it works.
The honest read
GH peptides raise growth hormone, and GH is genuinely involved in lipolysis. That is the mechanism the whole category rests on. But no GH peptide has demonstrated clinically meaningful fat loss in healthy adults in controlled trials, and the one component here designed and tested specifically for that purpose failed to beat placebo.
If fat loss is the goal, the variable with by far the largest evidence base behind it remains energy balance. That is not a satisfying answer, but it is the accurate one, and it is the reason this page will not tell you the blend is a fat-loss tool.
How to track AOD-9604 + CJC-1295 + Ipamorelin in Stackeddd
If you are running this, track the outcome you actually care about rather than the compound — weight trend, waist measurement and a photo interval will tell you more than any assumption about what three peptides are doing in combination.
Model it yourself · free, no account
Reconstitution Calculator
A blend is one reconstitution that sets the dose of every compound in the vial — get the water volume right once and every draw after it is correct.
Related compounds
Related reading: What peptides can you mix in the same syringe? · Peptide reconstitution math: how much BAC water to add
Frequently asked questions
Does AOD-9604 work for fat loss?
In its own phase-2b clinical trial it did not produce significantly greater weight loss than placebo, and it was not carried forward as an obesity drug on that basis. It is a fragment of growth hormone designed to isolate GH's fat-metabolising action, but that design goal was not borne out in the human trial data.
Is a three-peptide blend better than a two-peptide one?
The number of compounds in a vial is not a measure of effect. Three components in a fixed ratio also means less control — you cannot adjust one without moving the others — and three-way blends vary more between sellers than two-way ones.
Do GH peptides cause fat loss?
Growth hormone is genuinely involved in lipolysis, which is the mechanism the category rests on. But no GH peptide has demonstrated clinically meaningful fat loss in healthy adults in controlled trials, and raising a hormone is not the same as producing an outcome.
This is educational information, not medical advice. Doses and protocols above reflect published references and community practice — protocol decisions belong with your prescribing physician. Generic names used throughout. How this reference is built & how the AI is tested →
STACKEDDD
Track it instead of guessing.
Doses, reconstitution, bloodwork, and an AI coach grounded in your own data — free to start, on the App Store and Google Play.